MESA LABORATORIES, INC. designs, develops, acquires, manufactures and markets instruments and systems utilized in connection with industrial applications and hemodialysis therapy.
| Revenue (Most Recent Fiscal Year) | $249.13M |
| Net Income (Most Recent Fiscal Year) | $6.71M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | 17.23 |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 2.87 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 3.79 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 10.86 |
| Pre-Tax Margin (Trailing 12 Months) | 3.75% |
| Net Margin (Trailing 12 Months) | 1.92% |
| Return on Equity (Trailing 12 Months) | 22.72% |
| Return on Assets (Trailing 12 Months) | 9.82% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.79 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.32 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.73 |
| Inventory Turnover (Trailing 12 Months) | 3.31 |
| Book Value per Share (Most Recent Fiscal Quarter) | $33.73 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | $0.84 |
| Exchange | NASDAQ |
| Sector | Technology |
| Industry | Scientific & Technical Instruments |
| Common Shares Outstanding | 5.60M |
| Free Float | 5.44M |
| Market Capitalization | $715.54M |
| Average Volume (Last 20 Days) | 0.17M |
| Beta (Past 60 Months) | 0.96 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 2.80% |
| Percentage Held By Institutions (Latest 13F Reports) | 90.60% |
| Annual Dividend (Based on Last Quarter) | $0.64 |
| Dividend Yield (Based on Last Quarter) | 0.50% |